Upcoming Hepatitis C Trial
Share
Follow Us
The Editors at Hepatitis Central
March 15, 2013
Two pharmaceutical companies will work together next quarter on a mid-stage trial for an interferon-free Hepatitis C treatment.
Presidio Pharmaceuticals teams up with Boehringer Ingelheim on hepatitis C drug combo
Mar 13, 2013
Steven E.F. Brown, Web Editor- San Francisco Business Times
Presidio Pharmaceuticals Inc. will work on a hepatitis C treatment with help from Boehringer Ingelheim.
The two companies will test a combination of one Presidio drug and two Boehringer drugs in a Phase IIa clinical trial over 12 weeks. The tests begin in the second quarter of 2013.
Continue reading this entire article:
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/03/presidio-pharmaceuticals-teams-up-with.html
